CXPC(SH:600078)2023-10-27 16:00Financial Performance - The company's operating revenue for Q3 2023 was ¥968,950,598, a decrease of 25.68% compared to the same period last year[5]. - The net profit attributable to shareholders for Q3 2023 was ¥1,213,574, an increase of 101.47% year-on-year, while the net profit for the year-to-date period showed a decline of 121.80%[5][10]. - The company's revenue for the year-to-date period decreased by 33.45% due to a downturn in the chemical industry and a decline in product sales prices and volumes[9]. - Total operating revenue for the first three quarters of 2023 was CNY 2,429,495,846.63, a decrease from CNY 3,650,547,405.68 in the same period of 2022, representing a decline of approximately 33.5%[19]. - Total revenue from sales for the first three quarters of 2023 was 1,890,520,058.95 RMB, a decrease from 2,784,440,154.91 RMB in the same period of 2022, reflecting a decline of approximately 32.1%[23]. - The company's operating profit for Q3 2023 was -47,419,801.02 RMB, down from 833,295,993.79 RMB in Q3 2022[21]. - The total profit for Q3 2023 was -64,600,589.12 RMB, compared to 825,801,544.93 RMB in Q3 2022, showing a substantial decline in profitability[21]. - The total comprehensive income attributable to the parent company for Q3 2023 was -112,115,393.33 RMB, compared to 514,347,743.37 RMB in the same period last year[21]. Cash Flow and Assets - The net cash flow from operating activities for the year-to-date period was ¥478,885,796, reflecting an increase of 32.67%[6]. - The net cash flow from operating activities for the first three quarters of 2023 was 478,885,796.22 RMB, an increase from 360,958,481.42 RMB in the same period of 2022[23]. - The company's cash and cash equivalents stood at CNY 549,241,390.64 as of September 30, 2023, slightly up from CNY 543,165,964.17 at the end of 2022, an increase of about 1.0%[15]. - The cash inflow from financing activities totaled 56,000,000.00 CNY, down from 241,000,000.00 CNY in the previous period[24]. - The cash outflow from financing activities was 497,210,606.96 CNY, compared to 2,769,753,659.31 CNY in the previous period[24]. - The net cash flow from financing activities was -441,210,606.96 CNY, reflecting a decrease from -2,528,753,659.31 CNY in the previous period[24]. - The cash and cash equivalents at the end of the period were 445,472,996.98 CNY, down from 598,689,496.04 CNY at the end of the previous period[24]. - The company reported a total investment cash outflow of 88,355,567.87 CNY, slightly up from 85,015,876.98 CNY in the previous period[24]. Assets and Liabilities - The total assets at the end of the reporting period were ¥5,183,209,950, a decrease of 8.05% from the end of the previous year[6]. - The total assets as of September 30, 2023, amounted to CNY 5,183,209,949.57, compared to CNY 5,637,116,355.49 at the end of 2022, reflecting a decrease of approximately 8.1%[17]. - Current assets totaled CNY 1,769,289,377.70 as of September 30, 2023, down from CNY 2,138,785,729.23 at the end of 2022, a decline of about 17.3%[15]. - Total liabilities as of September 30, 2023, were CNY 2,903,534,166.20, compared to CNY 3,108,235,584.65 at the end of 2022, showing a decrease of approximately 6.6%[17]. Shareholder Information - The top two shareholders hold a combined 41.79% of the company's shares, with Wuxi Xingshengzhou Technology Partnership holding 25.78% and Jiangsu Huaxi Industrial Group holding 16.01%[12]. Cost Management - The company has implemented cost control measures that contributed to the increase in net profit for Q3 2023[9]. - The total operating costs for the first three quarters of 2023 were CNY 2,486,611,868.18, down from CNY 3,049,468,096.07 in 2022, indicating a reduction of about 18.5%[19]. - The company reported a decrease in sales expenses to 19,734,009.01 RMB in Q3 2023 from 16,895,226.89 RMB in Q3 2022, indicating cost control measures[21]. Research and Development - Research and development expenses in Q3 2023 were 4,769,285.82 RMB, a significant increase compared to 18,867.92 RMB in Q3 2022, indicating a focus on innovation[21]. Legal and Future Outlook - The company is currently involved in ongoing litigation with China Huarong Asset Management Co., Ltd., which may impact future financial performance[14]. - The company has not provided specific guidance for future performance or new product developments in the current report[14].